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TO THE EDITOR
Cholinergic urticaria (CU) is a sweat-
ing-associated, syringeal orifice-coinci-
dent wheal mediated by acetylcholine.
CU is occasionally associated with
depressed sweating, as reported under
the name of anhidrosis (complete lack
of sweating) or hypohidrosis (incom-
plete lack of sweating) (Itakura et al.,
2000). There have been reported 29
patients with CU with anhidrosis and/or
hypohidrosis (CUAH) (Kay and Maibach,
1969; Itakura et al., 2000; Yoshida
et al., 2009). One hypothesis for the
relationship between the wheal forma-
tion and the depressed sweating is that
the patients are hypersensitive to un-
known substance(s) in their sweat and
develop wheals in response to sweat
leaking from the syringeal ducts to the
dermis possibly by obstruction of the
ducts (Adachi et al., 1994; Kobayashi
et al., 2002). In fact, some patients with
common CU exhibit wheals to intra-
dermal injection of the patients’ own
diluted sweat as well as acetylcholine
and histologically show sweat duct
obstruction (Fukunaga et al., 2005).
However, none of the reported patients
with CUAH were positive to the in-
tradermally injected autologous sweat,
suggesting that ‘‘sweat hypersensitivity’’
is not responsible for CUAH. In addi-
tion, if sweat hypersensitivity is the
mechanism, the anhidrotic area should
be the predilection site for wheal, but
such an observation has not been
reported.
The study design was approved
by the review board of University
of Occupational and Environmental
Health. Measurements in this study
were performed after informed consent
had been obtained. The study was
conducted according to the Declaration
of Helsinki guidelines. To address its
mechanism, we investigated four non-
smoker male CUAH patients, aged 23
(case 1), 24 (case 2), 50 (case 3), and 36
years (case 4). The exercise challenge
and iodine–starch assessment for sweat
induction (Kobayashi et al., 2002)
revealed that the skin surfaces of all
patients were divided into the anhidro-
tic and hypohidrotic areas (Figure 1a).
The skin with normal sweating was not
seen in any patient. As represented by
case 1, the applied iodine–starch was
discolored by sweat in the hypohidrotic
but not anhidrotic area (Figure 1b, left),
and following exercise challenge, the
patients developed pinpoint wheals in
only the hypohidrotic areas (Figure 1b,
right). Intradermal injection of acetyl-
choline yielded wheal with sweating at
only the hypohidrotic areas (Figure 1c).
The injection of autologous sweat or
serum did not produce wheal in either
hypohidrotic or anhidrotic area. Histo-
logically, a periglandular lymphocytic
infiltrate was observed around eccrine
glands in the anhidrotic but not hypo-
hidrotic area of all patients (Figure 1d).
There was no occlusion of sweat ducts.
By immunohistochemistry, the infiltrat-
ing lymphocytes consisted of a mixture
of CD4þ and CD8þ T cells (CD4/CD8
ratio, 1.21; Figure 1e).
Skin sections were immunohisto-
chemically stained with anti-choliner-
gic receptor muscarin 3 (CHRM3)
antibody (H-210, 1:50; Santa Cruz
Biotechnology, Santa Cruz, CA), which
is the most important CHR for sweating
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(Schiavone and Brambilla, 1991).
Eccrine epithelial cells of a normal
subject expressed CHRM3 (Figure 2a,
left) as well as the epidermis and hair
follicle cells. Although the cells in the
hypohidrotic area bore CHRM3 at
lower but moderate levels (Figure 2a,
middle), no staining was seen in the
anhidrotic areas (Figure 2a, right).
Digitalized specimens were exported
to JPG files by NDP view software
(Hamamatsu Photonics, Hamamatsu,
Japan), and three different areas of the
cytoplasm of eccrine epithelial cells
were expressed as ‘‘red density’’ (RD)
(Hino et al., 2010). CHRM3 expression
was significantly lower in the anhidro-
tic than hypohidrotic areas (Figure 2b).
However, specificity is the major issue
in this immunohistochemical study.
Therefore, real-time PCR was per-
formed. Total RNA from serial sections
was extracted in cases 1, 2, and 4 and
reverse transcribed into complementary
DNA using the Qiagen RNeasy FFPE Kit
(Qiagen, Hilden, Germany) and first-
strand cDNA synthesis kit RT-PCR
(Roche Diagnostics, Indianapolis, IN).
The expression levels of CHRM3 and
controlGAPDH (glyceraldehyde-3-phos-
phate dehydrogenase) were examined
using 20 Assays-on-Demand Gene
Expression Assay Mix (Hs00265216_s1
and Hs00266705_g1, respectively; Ap-
plied Biosystems, Foster City, CA). We
performed PCR using RNAs without
Case 1 Case 2
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Anhidrosis
Hypohidrosis
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Hypohidrotic area Anhidrotic area
Acetylcholine injection
Hypohidrotic area Anhidrotic area CD4 CD8
Hypohidrotic area Anhidrotic area
Figure 1. Clinical and histological studies. (a) Anhidrotic and hypohidrotic areas in each case. (b) Left: Iodine–starch test in case 1. Whereas the applied
iodine–starch was discolored by sweat on the left shoulder (hypohidrotic area), such a black color change was not seen on the back, indicating the complete
absence of sweating (anhidrotic area). Right: Exercise challenge induced wheals that coincided with sweat orifice on the hypohidrotic area. (c) Acethylcholine
injection test in the anhidrotic and hypohidrotic areas as represented by case 1. After determination of the anhidrotic and hypohidrotic areas by exercise
challenge and iodine–starch application (upper panel), acetylcholine was injected at both sites. Wheal occurred at the hypohidrotic but not anhidrotic area
(lower panel). Bar¼1 cm. (d) Histological microphotographs of anhidrotic and hypohidrotic areas in case 1. Biopsy specimens were taken from the anhidrotic
and hypohidrotic areas (hematoxyline and eosin, original magnification  100). Note that lymphocytes infiltrate around the sweat glands in the anhidrotic but
not hypohidrotic area. Bar¼ 30 mm. (e) Immunophenotype of infiltrating lymphocytes. The infiltrating lymphocytes were immunohistochemically stained for
CD4 (left) and CD8 (right). Bar¼ 30 mm.
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reverse transcriptase step for each
sample. As represented in Figure 2d,
we did not amplify the CHRM3 gene
from any RNA without reverse transcrip-
tase (lane 1), but reverse transcriptase
step yielded PCR products at an ex-
pected size 72bp (lane 2), revealing
that positive CHRM3 PCR results of real-
time PCR were not derived from con-
taminated genomic DNA. The levels
of CHRM3 expression were higher in
the hypohidrotic than anhidrotic areas
(Figure 2e).
As mast cells produce histamine
in response to acetylcholine (Fantozzi
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Figure 2. Expression of anti-cholinergic receptor muscarin 3 (CHRM3) in eccrine gland epithelial cells and mast cells. (a) CHRM3 expression in eccrine gland
epithelial cells. Sections from normal subject’s skin (left), and the hypohidrotic skin (middle) and anhidrotic skin (right) of case 1 were immunohistochemically
stained with anti-CHRM3 antibody. Bar¼ 30 mm. (b) Staining intensity of CHRM3 expressed as ‘‘red density’’ (RD) in the anhidrotic and hypohidrotic areas
of the four cases and in the skin of a normal subject. Three areas of eccrine epithelial cells at the anhidrotic and hypohidrotic areas in each case were subjected
to RD analysis, and the mean RD intensity in each case was obtained. Then, the mean±SD of the four cases was calculated. (c) CHRM3 expression in
mast cells. Skin sections of a normal subject (control) and the hypohidrotic and anhidrotic skin of the patients were stained with toluidine blue (upper panel)
or immunohistochemically with CHRM3 (lower panel). Serial sections of each specimen were alternatively stained for CHRM3 and toluidine blue.
Mast cells were identified by toluidine blue (arrows). The corresponding sections for toluidine blue and CHRM3 are adjacent. Bar¼ 30mm. (d) mRNA expression
for CHRM3. The end products of real-time PCR using RNA without reverse transcriptase reaction (lane 1) and complementary DNA (cDNA) (lane 2) from
hypohidrotic skin of case 1 were electrophoresed in 1.8% agarose gel along with 100 bp DNA ladder (Takara, Kyoto, Japan). CHRM3 gene products were
recognized at an expected size, 72 bp, only in lane 2. (e) The expression levels of CHRM3 and control GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
in the hypohidrotic and anhidrotic areas by real-time PCR analysis. Total RNA from serial sections was extracted in cases 1, 2, and 4 and reverse transcribed
into cDNA using first-strand cDNA synthesis kit RT-PCR.
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et al., 1978; Blandina et al., 1980), we
investigated CHR expression in mast
cells just in vicinity of eccrine glands.
Serial sections were alternatively
stained with toluidine blue and with
anti-CHRM3 antibody. Mast cells were
identified by positive toluidine blue
staining (Figure 2c, upper panel), and
CHRM3 expression by mast cells was
examined in the antibody-stained adja-
cent sections (Figure 2c, lower panel).
In a normal control, mast cells expressed
CHRM3 at high levels. Mast
cells in conjunction with the secretory
portion expressed CHRM3 in the hypo-
hidrotic but not anhidrotic areas. There
was no significant difference in the
number of mast cells between the
anhidrotic and hypohidrotic areas.
Our study revealed that the skin of
patients with CUAH is divided into the
wheal-non-occuring anhidrotic and
wheal-occuring hypohidrotic areas.
Even in the hypohidrotic areas, the
intradermal injection of autologous
sweat did not yield wheal, suggesting
the absence of sweat allergy (Tsuchiya
et al., 2004). We found the lack of
CHRM3 expression in the anhidrotic
skin, which may lead to the lack of
sensitivity to acetylcholine. Mast cells
are responsible for wheal formation and
present just in the vicinity of eccrine
glands. Neither eccrine gland cells nor
mast cells expressed CHRM3 in the
anhidrotic area, and it is thus reasonable
that sweating and wheal formation were
absent in this area. CHR mediates wheal
development (Tong et al., 1997), and
acetylcholine can induce degranulation
of mast cells (Fantozzi et al., 1978;
Blandina et al., 1980). In the hypohidrotic
area, we are tempting to speculate that
acetylcholine released from nerves upon
exercise cannot be completely trapped by
CHR of eccrine glands and overflows to
the adjacent mast cells. In this scenario,
mast cells may be capable of producing
histamine and resultant wheal in response
to acetylcholine because of the expres-
sion of some degree of CHRM3.
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TO THE EDITOR
Cutaneous squamous cell carcinoma
(SCC) is the second most common skin
malignancy in the general population.
There are many risk factors for SCC, the
most important one being solar radia-
tion. The incidence of SCC is increased
by 60–100-fold in organ transplant
recipients (OTRs), making it the most
common malignancy in these patients
(Berg and Otley, 2002; Euvrard et al.,
2003). SCC in OTRs is characterized
by a higher risk of metastasis in up
to 20% of the patients and shows a
more aggressive course than SCC in
the general population (Euvrard et al.,
2003).
Recent work has delineated a class
of small non-coding RNA species
known as microRNAs. Owing to their
association with the 30-untranslated
region region of target mRNAs, micro-
RNAs have important regulatory roles
in diverse cellular pathways, including
Abbreviations: OTR, organ transplant recepient; SCC, squamous cell carcinoma; UTR, untranslated
region
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